APOMORPHINE | APOMORPHINE | ATC G04BE07 ATC N04BC07
NERVOUS SYSTEM ANTIDYSKINETICS ANTIPARKINSON AGENTS NON-ERGOLINE DOPAMINE AGONIST D4 (KI = 4.4 NANOMOLAR) D2 (KI = 35 NANOMOLAR) D3 (KI = 26 NANOMOLAR) D5 (KI = 15 NANOMOLAR) | SUBCUTANEOUS SUBLINGUAL | F 100 PERCENT VD 218 LITER PPB 94 PERCENT Cl 223 LITER / HOUR HT 0.66 HOUR SOLUBILITY SOLUBLE IN WATER | DOPAMINE D2 RECEPTOR PDB 7JVQ (CRYO-EM STRUCTURE OF APOMORPHINE-BOUND DOPAMINE RECEPTOR 1 IN COMPLEX WITH GS PROTEIN) LIGAND CODE = OR9 (link to the list of PDB complexes) Download experimental 3D coordinates of OR9 with added hydrogens | D(2) dopamine receptor UNIPROT P14416 DRD2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |